Pfizer-BioNTech will soon request FDA emergency authorization for a second Covid booster shot for people 65 and older, a group for which the agency has previously been quick to approve new shots, the Washington Post reported.
Pfizer-BioNTech will soon request FDA emergency authorization for a second Covid booster shot for people 65 and older, a group for which the agency has previously been quick to approve new shots, the Washington Post reported.